CD59 and inflammatory bowel disease: It is also proposed that there could be a defect in the synthesis (or inadequate formation) of lipoxins, resolvins, protectins and maresins from PUFAs and in response to alpha7nAChR and VNS in those who respond poorly to treatment and who have aggressive RA and lupus autoimmune diseases and inflammatory conditions such as inflammatory bowel diseases.